Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of British Columbia

$21,487.00

Integrating neural, neurochemical and molecular mechanisms of impulse control

FY 2008-09

Summary
Impulsivity is both a beneficial and detrimental human characteristic, allowing us to seize a valuable opportunity or to make a disastrous decision we live to regret. A high level of impulsivity is a key symptom in psychiatric disorders such as bipolar disorder and attention-deficit hyperactivity disorder (AD/HD). Improving our understanding of the biological basis of impulsivity could provide valuable insight into the nature of these illnesses. Recent evidence suggests that the neurotransmitter noradrenaline may be important in the regulation of impulsivity, and novel drugs which modulate the activity of this system may offer alternatives to stimulant medication for AD/HD. Increases in noradrenergic activity have also been shown to trigger mania in bipolar patients. We have recently found that the drug yohimbine, which increases noradrenaline levels in the brain, also increases impulsive responding in rats. We intend to determine which noradrenergic receptors in which brain regions are responsible for effecting this change in impulsive behaviour. We wish to use this knowledge, together with what is known regarding the effects of other pharmacological agents active at different neurotransmitter systems, in order to understand how drugs which alter impulse control may converge on similar intracellular signaling pathways. Such information could generate a "molecular footprint" for impulsivity, linking behaviour to molecular biology, which could in time open up new avenues for therapeutic treatment for impulse control disorders.
Program
Discovery Grants Program - Individual
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
341483-2007
Name nom
Winstanley, Catharine
Department département
Psychology
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2007
Award amount
21487
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
12
Committee name en
Psychology: Brain, Behaviour & Cognitive Sciences
Committee name fr
Psychologie: Cerveau, comportement et science cognitive
Area of application code
1210
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Psychology
Area of application fr
Psychologie
Research subject code
6310
Research subject group en
Psychology
Research subject group fr
Psychologie
Research subject en
Behavioural neuroscience --reward, motivation
Research subject fr
Neurologie du comportement --récompense, motivation
Partie
2
Nb partie
5
Application title
Integrating neural, neurochemical and molecular mechanisms of impulse control
Keyword
NA
Application summary
Impulsivity is both a beneficial and detrimental human characteristic, allowing us to seize a valuable opportunity or to make a disastrous decision we live to regret. A high level of impulsivity is a key symptom in psychiatric disorders such as bipolar disorder and attention-deficit hyperactivity disorder (AD/HD). Improving our understanding of the biological basis of impulsivity could provide valuable insight into the nature of these illnesses. Recent evidence suggests that the neurotransmitter noradrenaline may be important in the regulation of impulsivity, and novel drugs which modulate the activity of this system may offer alternatives to stimulant medication for AD/HD. Increases in noradrenergic activity have also been shown to trigger mania in bipolar patients. We have recently found that the drug yohimbine, which increases noradrenaline levels in the brain, also increases impulsive responding in rats. We intend to determine which noradrenergic receptors in which brain regions are responsible for effecting this change in impulsive behaviour. We wish to use this knowledge, together with what is known regarding the effects of other pharmacological agents active at different neurotransmitter systems, in order to understand how drugs which alter impulse control may converge on similar intracellular signaling pathways. Such information could generate a "molecular footprint" for impulsivity, linking behaviour to molecular biology, which could in time open up new avenues for therapeutic treatment for impulse control disorders.